Vergoeding 2017-2021 voor ATC-subgroep A10BK : Natriumglucose-cotransporter-2-remmers (sglt-2-remmers)
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| A10BK01 Dapagliflozine (Forxiga ®) | 2.279.800 | 2.952.400 | 2.900.400 | 3.344.500 | 5.377.000 |
| A10BK02 Canagliflozine (Invokana ®) | 116.580 | 184.570 | 323.010 | 490.490 | 668.830 |
| A10BK03 Empagliflozine (Jardiance ®) | 1.273.200 | 2.399.000 | 2.959.500 | 3.538.100 | 4.102.600 |
| A10BK04 Ertugliflozine (Steglatro ®) | . | . | 3.560 | 6.492 | 7.325 |
| Totaal | 3.669.580 | 5.535.970 | 6.186.470 | 7.379.582 | 10.155.755 |